Holdings
Rtw Investments, LP
As of Jun 30, 2026, Rtw Investments, LP reported 73 positions worth US$10.5B. Largest: Madrigal Pharmaceuticals, Inc., Argenx Se and Ptc Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. | 1.99M | US$1.07B | no change | Jun 30, 2026 |
| Argenx Se | 709K | US$658M | no change | Jun 30, 2026 |
| Ptc Therapeutics, Inc. | 7.75M | US$632M | no change | Jun 30, 2026 |
| Protagonist Therapeutics, Inc. | 5.06M | US$620M | +2,122 | Jun 30, 2026 |
| Cg Oncology, Inc. | 8.51M | US$605M | +1.53M | Jun 30, 2026 |
| Insmed Incorporated | 4.84M | US$516M | no change | Jun 30, 2026 |
| Tango Therapeutics, Inc. | 13.9M | US$435M | +600K | Jun 30, 2026 |
| Spyre Therapeutics, Inc. | 4.25M | US$377M | +80,000 | Jun 30, 2026 |
| Celcuity Inc. | 3.3M | US$346M | +265K | Jun 30, 2026 |
| Erasca, Inc. | 17.9M | US$329M | +1.79M | Jun 30, 2026 |